Gene Biotherapeutics (CRXM) Short Interest Ratio & Short Volume → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free CRXM Stock Alerts Add Compare Share Share Short InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Gene Biotherapeutics Short Interest DataCurrent Short Volume100 sharesPrevious Short Volume100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$0.00Short Interest Ratio / Days to Cover0.0Last Record DateMarch 31, 2024Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Gene Biotherapeutics ? Sign up to receive the latest short interest report for Gene Biotherapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCRXM Short Interest Over TimeCRXM Days to Cover Over TimeCRXM Percentage of Float Shorted Over Time Ad Crypto 101 Media[Shocking] Elon Musk’s Plan To End BanksLeaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030. Click here now to get your copy. Gene Biotherapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2024100 shares $0.00 No ChangeN/A0 $0.00 3/15/2024100 shares $0.00 No ChangeN/A0 $0.00 2/29/2024100 shares $0.00 No ChangeN/A0 $0.00 2/15/2024100 shares $0.00 No ChangeN/A1 $0.00 1/15/2024100 shares $0.00 No ChangeN/A0 $0.00 12/31/2023100 shares $0.00 No ChangeN/A0 $0.00 Get the Latest News and Ratings for CRXM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gene Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/2023100 shares $0.00 No ChangeN/A0 $0.00 11/30/2023100 shares $0.00 No ChangeN/A0.2 $0.00 11/15/2023100 shares $0.00 No ChangeN/A0 $0.00 10/31/2023100 shares $0.00 No ChangeN/A0 $0.00 10/15/2023100 shares $0.00 No ChangeN/A0 $0.00 9/30/2023100 shares $0.00 No ChangeN/A1 $0.00 9/15/2023100 shares $0.00 No ChangeN/A0 $0.00 8/31/2023100 shares $0.00 No ChangeN/A49.5 $0.00 8/15/2023100 shares $0.00 No ChangeN/A1 $0.00 7/31/2023100 shares $0.00 No ChangeN/A0.1 $0.00 7/15/2023100 shares $0.00 No ChangeN/A0 $0.00 6/30/2023100 shares $0.00 No ChangeN/A0 $0.00 6/15/2023100 shares $0.00 No ChangeN/A0 $0.00 5/31/2023100 shares $0.00 No ChangeN/A1 $0.00 5/15/2023100 shares $0.00 No ChangeN/A0.5 $0.00 4/30/2023100 shares $0.00 No ChangeN/A0.1 $0.00 4/15/2023100 shares $0.00 No ChangeN/A0 $0.00 3/31/2023100 shares $0.00 No ChangeN/A1 $0.00 3/15/2023100 shares $0.00 No ChangeN/A0 $0.00 2/28/2023100 shares $0.00 No ChangeN/A0 $0.00 2/15/2023100 shares $0.00 No ChangeN/A1 $0.00 1/31/2023100 shares $0.00 No ChangeN/A1 $0.00 1/15/2023100 shares $0.00 No ChangeN/A0 $0.00 12/30/2022100 shares $0.00 No ChangeN/A0 $0.00 12/15/2022100 shares $0.00 No ChangeN/A0 $0.00 11/30/2022100 shares $0.00 No ChangeN/A1 $0.00 11/15/2022100 shares $0.00 No ChangeN/A0 $0.00 10/31/2022100 shares $0.00 No ChangeN/A0 $0.00 10/15/2022100 shares $0.00 No ChangeN/A1 $0.00 9/30/2022100 shares $0.00 No ChangeN/A0 $0.00 9/15/2022100 shares $0.00 No ChangeN/A1 $0.00 8/31/2022100 shares $0.00 No ChangeN/A1 $0.00 8/15/2022100 shares $0.00 No ChangeN/A0.1 $0.00 7/31/2022100 shares $0.00 No ChangeN/A0.3 $0.00This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry CRXM Short Interest - Frequently Asked Questions What is Gene Biotherapeutics' current short interest? Short interest is the volume of Gene Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 100 shares of CRXM short. Learn More on Gene Biotherapeutics' current short interest. How does Gene Biotherapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Gene Biotherapeutics: Abliva AB (publ) (0.00%), ADM Tronics Unlimited, Inc. (0.02%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Gene Biotherapeutics stock? Short selling CRXM is an investing strategy that aims to generate trading profit from Gene Biotherapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gene Biotherapeutics? A short squeeze for Gene Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CRXM, which in turn drives the price of the stock up even further. How often is Gene Biotherapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRXM, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: ENZN Short Squeeze QNNTF Short Squeeze TNGNQ Short Squeeze ATNFW Short Squeeze TGIFF Short Squeeze TRSBF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ABCZF Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CRXM) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media